| Identification of the receptor component of the IκBα–ubiquitin ligase A Yaron, A Hatzubai, M Davis, I Lavon, S Amit, AM Manning, JS Andersen, ... Nature 396 (6711), 590-594, 1998 | 904 | 1998 |
| Neural precursors attenuate autoimmune encephalomyelitis by peripheral immunosuppression O Einstein, N Fainstein, I Vaknin, R Mizrachi‐Kol, E Reihartz, ... Annals of Neurology: Official Journal of the American Neurological …, 2007 | 295 | 2007 |
| Anti-inflammatory properties of cholinergic up-regulation: a new role for acetylcholinesterase inhibitors E Nizri, Y Hamra-Amitay, C Sicsic, I Lavon, T Brenner Neuropharmacology 50 (5), 540-547, 2006 | 244 | 2006 |
| In vivo stimulation of IκB phosphorylation is not sufficient to activate NF-κB I Alkalay, A Yaron, A Hatzubai, S Jung, A Avraham, O Gerlitz, ... Molecular and Cellular Biology 15 (3), 1294-1301, 1995 | 216 | 1995 |
| Transplanted neural precursor cells reduce brain inflammation to attenuate chronic experimental autoimmune encephalomyelitis O Einstein, N Grigoriadis, R Mizrachi-Kol, E Reinhartz, E Polyzoidou, ... Experimental neurology 198 (2), 275-284, 2006 | 206 | 2006 |
| High susceptibility to bacterial infection, but no liver dysfunction, in mice compromised for hepatocyte NF-κB activation I Lavon, I Goldberg, S Amit, L Landsman, S Jung, BZ Tsuberi, I Barshack, ... Nature medicine 6 (5), 573-577, 2000 | 205 | 2000 |
| Serum DNA can define tumor-specific genetic and epigenetic markers in gliomas of various grades I Lavon, M Refael, B Zelikovitch, E Shalom, T Siegal Neuro-oncology 12 (2), 173-180, 2010 | 177 | 2010 |
| Novel Mechanism whereby Nuclear Factor κB Mediates DNA Damage Repair through Regulation of O6-Methylguanine-DNA-Methyltransferase I Lavon, D Fuchs, D Zrihan, G Efroni, B Zelikovitch, Y Fellig, T Siegal Cancer research 67 (18), 8952-8959, 2007 | 172 | 2007 |
| Gliomas display a microRNA expression profile reminiscent of neural precursor cells I Lavon, D Zrihan, A Granit, O Einstein, N Fainstein, MA Cohen, ... Neuro-oncology 12 (5), 422-433, 2010 | 162 | 2010 |
| Progressive low‐grade oligodendrogliomas: Response to temozolomide and correlation between genetic profile and O6‐methylguanine DNA methyltransferase … N Levin, I Lavon, B Zelikovitsh, D Fuchs, F Bokstein, Y Fellig, T Siegal Cancer: Interdisciplinary International Journal of the American Cancer …, 2006 | 153 | 2006 |
| Suppression of neuroinflammation and immunomodulation by the acetylcholinesterase inhibitor rivastigmine E Nizri, M Irony-Tur-Sinai, N Faranesh, I Lavon, E Lavi, M Weinstock, ... Journal of neuroimmunology 203 (1), 12-22, 2008 | 136 | 2008 |
| Temozolomide treatment for newly diagnosed anaplastic oligodendrogliomas: a clinical efficacy trial A Taliansky-Aronov, F Bokstein, I Lavon, T Siegal Journal of neuro-oncology 79, 153-157, 2006 | 69 | 2006 |
| Dynamics of circulating hypoxia-mediated miRNAs and tumor response in patients with high-grade glioma treated with bevacizumab T Siegal, H Charbit, I Paldor, B Zelikovitch, T Canello, A Benis, ML Wong, ... Journal of neurosurgery 125 (4), 1008-1015, 2016 | 61 | 2016 |
| Androgen receptor: a potential therapeutic target for glioblastoma N Zalcman, T Canello, H Ovadia, H Charbit, B Zelikovitch, A Mordechai, ... Oncotarget 9 (28), 19980, 2018 | 58 | 2018 |
| Nuclear factor-κB protects the liver against genotoxic stress and functions independently of p53 I Lavon, E Pikarsky, E Gutkovich, I Goldberg, J Bar, M Oren, Y Ben-Neriah Cancer research 63 (1), 25-30, 2003 | 53 | 2003 |
| Longitudinal assessment of genetic and epigenetic markers in oligodendrogliomas I Lavon, D Zrihan, B Zelikovitch, Y Fellig, D Fuchs, D Soffer, T Siegal Clinical cancer research 13 (5), 1429-1437, 2007 | 52 | 2007 |
| Time limited immunomodulatory functions of transplanted neural precursor cells N Fainstein, O Einstein, ME Cohen, L Brill, I Lavon, T Ben‐Hur Glia 61 (2), 140-149, 2013 | 41 | 2013 |
| Circulating microRNAs as biomarkers for rituximab therapy, in neuromyelitis optica (NMO) A Vaknin-Dembinsky, H Charbit, L Brill, O Abramsky, D Gur-Wahnon, ... Journal of neuroinflammation 13, 1-8, 2016 | 30 | 2016 |
| A novel synthetic cannabinoid derivative inhibits inflammatory liver damage via negative cytokine regulation I Lavon, T Sheinin, S Meilin, E Biton, A Weksler, G Efroni, A Bar-Joseph, ... Molecular pharmacology 64 (6), 1334-1341, 2003 | 30 | 2003 |
| Blood levels of co-inhibitory-receptors: a biomarker of disease prognosis in multiple sclerosis I Lavon, C Heli, L Brill, H Charbit, A Vaknin-Dembinsky Frontiers in Immunology 10, 445292, 2019 | 29 | 2019 |
Ofira EinsteinAssociate Prof. of Neurobiology, Physiotherapy Dep., Dean, Health Sciences Faculty, Ariel UniversityVerified email at ariel.ac.il
